Some pharmacokinetic parameters of salvianolic acid A following single-dose oral administration to rats

References

• Cai H, Su S, Li Y, Zeng H, Zhu Z, Guo J, Zhu Y, Guo S, Yu L, Qian D, et al. 2018. Protective effects of Salvia miltiorrhiza on adenine-induced chronic renal failure by regulating the metabolic profiling and modulating the NADPH oxidase/ROS/ERK and TGF-β/Smad signaling pathways. J Ethnopharmacol. 212:153–165.
   PubMed Web of Science ®Google Scholar
• Chang BB, Zhang L, Cao WW, Cao Y, Yang WL, Wang Y, Chen YC, Liu XQ. 2010. Pharmacokinetic interactions induced by content variation of major water-soluble components of Danshen preparation in rats. Acta Pharmacol Sin. 31:638–646.
   PubMed Web of Science ®Google Scholar
• Chen Q, Xu T, Li D, Pan D, Wu P, Luo Y, Ma Y, Liu Y. 2016. JNK/PI3K/Akt signaling pathway is involved in myocardial ischemia/reperfusion injury in diabetic rats: effects of salvianolic acid A intervention. Am J Transl Res. 8:2534–2548.
   PubMed Web of Science ®Google Scholar
• Du GH, Zhang WK, Zhang L, Zhao Y, Wang SB, Yang HG, Tian S, Inventors. INST MATERIA MEDICA CAMS, Assignee. 2012. Method for preparing salvianolic acid A bulk drug. China patent CN102731308A.
   Google Scholar
• Feng SQ, Aa N, Geng JL, Huang JQ, Sun RB, Ge C, Yang ZJ, Wang LS, Aa JY, Wang GJ. 2017. Pharmacokinetic and metabolomic analyses of the neuroprotective effects of salvianolic acid A in a rat ischemic stroke model. Acta Pharmacol Sin. 38:1435–1444.
   PubMed Web of Science ®Google Scholar
• Gu X, Zheng C, Zheng Q, Chen S, Li W, Shang Z, Zhang H. 2017. Salvianolic acid A attenuates early brain injury after subarachnoid hemorrhage in rats by regulating ERK/P38/Nrf2 signaling. Am J Transl Res. 9:5643–5652.
   PubMed Web of Science ®Google Scholar
• Han DE, Zheng Y, Chen X, He J, Zhao D, Yang S, Zhang C, Yang Z. 2012. Identification and characterization of human UDP–glucuronosyltransferases responsible for the in vitro glucuronidation of salvianolic acid A. Drug Metab Pharmacokinetics. 27:579–585.
   PubMed Web of Science ®Google Scholar
• Hou B, Qiang G, Zhao Y, Yang X, Chen X, Yan Y, Wang X, Liu C, Zhang L, Du G. 2017. Salvianolic acid A protects against diabetic nephropathy through ameliorating glomerular endothelial dysfunction via inhibiting AGE–RAGE signaling. Cell Physiol Biochem. 44:2378–2394.
   PubMed Web of Science ®Google Scholar
• Huang W, Yang Y, Zeng Z, Su M, Gao Q, Zhu B. 2016. Effect of Salvia miltiorrhiza and ligustrazine injection on myocardial ischemia/reperfusion and hypoxia/reoxygenation injury. Mol Med Rep. 14:4537–4544.
   PubMed Web of Science ®Google Scholar
• Lai XJ, Zhang L, Li JS, Liu HQ, Liu XH, Di LQ, Cai BC, Chen LH. 2011. Comparative pharmacokinetic and bioavailability studies of three salvianolic acids after the administration of Salviae miltiorrhizae alone or with synthetical borneol in rats. Fitoterapia 82:883–888.
   PubMed Web of Science ®Google Scholar
• Liu DF, Wen HL, Li ZY, Cheng F, Yang XL. 2011. Stability study of salvianolic acid A in aqueous solution. Jiangxi J Trad Chin Med. 42:58–59.
   Google Scholar
• Lu T, Yang J, Gao X, Chen P, Du F, Sun Y, Wang F, Xu F, Shang H, Huang Y, et al. 2008. Plasma and urinary tanshinol from Salvia miltiorrhiza (Danshen) can be used as pharmacokinetic markers for cardiotonic pills, a cardiovascular herbal medicine. Drug Metab Dispos. 36:1578–1586.
   PubMed Web of Science ®Google Scholar
• Pei L, Bao Y, Wang H, Yang F, Xu B, Wang S, Yang X, Du G. 2008. A sensitive method for determination of salvianolic acid A in rat plasma using liquid chromatography/tandem mass spectrometry. Biomed Chromatogr. 22:786–794.
   PubMed Web of Science ®Google Scholar
• Shen Y, Wang X, Xu L, Liu X, Chao R. 2009. Characterization of metabolites in rat plasma after intravenous administration of salvianolic acid A by liquid chromatography/time-of-flight mass spectrometry and liquid chromatography/ion trap mass spectrometry. Rapid Commun Mass Spectrom. 23:1810–1816.
   PubMed Web of Science ®Google Scholar
• Sun J, Zhang L, Song J, Tian S, Huang C, Feng Z, Lv Y, Du G. 2013. Pharmacokinetic study of salvianolic acid A in beagle dog after oral administration by a liquid chromatography–mass spectrometry method: a study on bioavailability and dose proportionality. J Ethnopharmacol. 148:617–623.
   PubMed Web of Science ®Google Scholar
• Wang H, Li X, Zhang W, Liu Y, Wang S, Liu X, He H. 2017. Mechanism-based pharmacokinetic-pharmacodynamic modeling of salvianolic acid A effects on plasma xanthine oxidase activity and uric acid levels in acute myocardial infarction rats. Xenobiotica 47:208–216.
   PubMed Web of Science ®Google Scholar
• Wang SP, Liu L, Wang LL, Jiang P, Xiang L, Zhang WD, Liu RH. 2013. Simultaneous determination of six hydrophilic components in rat plasma after oral administration of Jitai tablet by liquid chromatography-electrospray ionization–tandem mass spectrometry: application to a pharmacokinetic study. J Chromatogr B Anal Technol Biomed Life Sci. 912:75–84.
   PubMed Web of Science ®Google Scholar
• Xu J, Zeng S, Chen X, Qu H. 2011. Isolation and identification of degradation products of salvianolic acid A by NMR and LC–MS. Fitoterapia 82:260–266.
   PubMed Web of Science ®Google Scholar
• Xu JZ, Shen J, Cheng YY, Qu HB. 2008. Simultaneous detection of seven phenolic acids in Danshen injection using HPLC with ultraviolet detector. J Zhejiang Univ Sci B. 9:728–733.
   PubMed Web of Science ®Google Scholar
• Xu X, Hu Y, Zhai X, Lin M, Chen Z, Tian X, Zhang F, Gao D, Ma X, Lv L, et al. 2013. Salvianolic acid A preconditioning confers protection against concanavalin A-induced liver injury through SIRT1-mediated repression of p66shc in mice. Toxicol Appl Pharmacol. 273:68–76.
   PubMed Web of Science ®Google Scholar
• Yang XY, Qiang GF, Zhang L, Zhu XM, Wang SB, Sun L, Yang HG, Du GH. 2011a. Salvianolic acid A protects against vascular endothelial dysfunction in high-fat diet fed and streptozotocin-induced diabetic rats. J Asian Nat Prod Res. 13:884–894.
   PubMed Web of Science ®Google Scholar
• Yang XY, Sun L, Xu P, Gong LL, Qiang GF, Zhang L, Du GH. 2011b. Effects of salvianolic acid A on plantar microcirculation and peripheral nerve function in diabetic rats. Eur J Pharmacol. 665:40–46.
   PubMed Web of Science ®Google Scholar
• Yang Z, Gao S, Yin T, Kulkarni KH, Teng Y, You M, Hu M. 2010. Biopharmaceutical and pharmacokinetic characterization of matrine as determined by a sensitive and robust UPLC–MS/MS method. J Pharm Biomed Anal. 51:1120–1127.
   PubMed Web of Science ®Google Scholar
• Yu X, Zhang L, Yang X, Huang H, Huang Z, Shi L, Zhang H, Du G. 2012. Salvianolic acid A protects the peripheral nerve function in diabetic rats through regulation of the AMPK-PGC1α-Sirt3 axis. Molecules (Basel, Switzerland) 17:11216–11228.
   Google Scholar
• Yuan X, Xiang Y, Zhu N, Zhao X, Ye S, Zhong P, Zeng C. 2017. Salvianolic acid A protects against myocardial ischemia/reperfusion injury by reducing platelet activation and inflammation. Exp Ther Med. 14:961–966.
   PubMed Web of Science ®Google Scholar
• Zhang L, Dai SZ, Nie XD, Zhu L, Xing F, Wang LY. 2013. Effect of Salvia miltiorrhiza on retinopathy. Asian Pac J Trop Med. 6:145–149.
   PubMed Web of Science ®Google Scholar
• Zhao D, Han DE, Li N, Lu Y, Li TT, Yang SY, He JK, Chen XJ. 2011. Simultaneous determination of six phenolic constituents of Danshen injection in rat plasma by LC–ESI–MS and its application to a pharmacokinetic study. Eur J Mass Spectrom. 17:395–403.
   PubMed Web of Science ®Google Scholar
• Zheng X, Chen S, Yang Q, Cai J, Zhang W, You H, Xing J, Dong Y. 2015. Salvianolic acid A reverses the paclitaxel resistance and inhibits the migration and invasion abilities of human breast cancer cells by inactivating transgelin 2. Cancer Biol Ther. 16:1407–1414.
   PubMed Web of Science ®Google Scholar